Marci English

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

Samuel Lederman, Faith D Ottery, Antonio Cano et al. · The Lancet · 2023 · 219 citations

Phase 3, Gynecology, Menopausal Hormone Therapy +12

Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

Kimball A. Johnson, Nancy Martin, Rossella E. Nappi et al. · The Journal of Clinical Endocrinology & Metabolism · 2023 · 173 citations · Full text

Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause

Genevieve Neal-Perry, Antonio Cano, Samuel Lederman et al. · Obstetrics and Gynecology · 2023 · 96 citations · Full text

Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS Sleep Disturbance and Sleep-Related Impairment measures for assessment of VMS impact on sleep

Marci English, Boyka Stoykova, Christina Slota et al. · Journal of Patient-Reported Outcomes · 2021 · 47 citations · Full text

Hospital infection: from Miasmas to MRSA.

G.A.J. Ayliffe, Marci English · 2003 · 28 citations

Pathogenic Microbiology, Antibiotics, Healthcare-associated Infection +5